Modulo Bio
PrivateLast Round
Strategic
Mar 19, 2025
Total Funding Raised
$19.15M
Company Overview
Modulo Bio operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Strategic round in March 2025.
Modulo Bio is a biotechnology company that develops treatments for neurodegenerative disorders by reprogramming the brain's immune system.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Modulo Bio Comparables
Compare Modulo Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AcuraStem | 85% | |
| Monument Biosciences | 81% | |
| Muna Therapeutics | 79% |
For institutional investors. Book with your work email.
Modulo Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Mar 19, 2025 | ||||
| Grant | Feb 7, 2025 | ||||
| Seed | Dec 5, 2024 | ||||
| Seed | Jun 1, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Modulo Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The ALS Association | Grant |
| Refactor Capital | Seed |
| Builders VC | Seed |
| Cantos Ventures | Seed |
| Hawktail Management | Seed |
| Bioverge | Seed |
| Initialized Capital Management | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 19, 2025
$4.8M raised in early funding.
- Feb 7, 2025
$500K raised in a Grant round.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_awardOct 20, 2026
Modulo receives the 2024 Barnett Drug Development Award from The ALS Association.
For institutional investors. Book with your work email.
Modulo Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Modulo Bio's valuation, stock price, and market status.
Is Modulo Bio a public or private company?
Modulo Bio is a private company.
What is the current stock price of Modulo Bio?
Modulo Bio is a private company, so its shares have no public market price. Caplight tracks Modulo Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Modulo Bio worth (valuation)?
Valuation information for Modulo Bio is not publicly available.
Can I buy Modulo Bio stock?
Modulo Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Modulo Bio's last funding round?
Modulo Bio's most recent funding round was Strategic on March 19, 2025.
Who are the main investors in Modulo Bio?
Key investors in Modulo Bio include Alzheimer's Drug Discovery Foundation.
Will Modulo Bio IPO soon?
No public IPO plans have been announced for Modulo Bio.
How can I track Modulo Bio secondary market activity?
Caplight tracks bids, offers, and trades in Modulo Bio's shares on secondary markets.